Macleods Pharma Usa Inc recalls Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., P…
- Recall date
- September 23, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0140-2020
- FDA classification
- Class II
- Brand / firm
- Macleods Pharma Usa Inc
- Sold / distributed
- Product was shipped to 8 distributors who may have further distributed the product.
Why it was recalled
Superpotent
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07
Get recall alerts
Free email alert whenever Macleods Pharma Usa Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Macleods Pharma Usa Inc